Meyka Pro banner
HEXO Corp.

HEXO Corp. (HEXO) Stock Overview

Explore HEXO Corp.’s financial performance, market position, analyst ratings, and future outlook.

HEXONASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.71
$0.02(2.45%)
U.S. Market is Open · 14:50

HEXO Corp. (HEXO)

Meyka AI Score

Z

Key Financials

Market Cap31.2M
P/E Ratio-0.03
EPS (TTM)$-2.77
ROE-2.06%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

HEXO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of HEXO Corp. (NASDAQ: HEXO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, HEXO Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HEXO on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind HEXO Corp.'s NASDAQ-traded stock include a P/E ratio of -0.03 and a market capitalization of 31.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HEXO on the NASDAQ.

Price Performance (NASDAQ: HEXO)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-39.83%
6-Month Change
-52.67%
Year-to-Date (YTD) Change
-29.70%
1-Year Change
-74.30%
3-Year Change
-98.23%
5-Year Change
-99.62%
All-Time (Max) Change
-99.15%

Contact Information

18444061852
120 Chemin de la Rive, Gatineau, QC, NaN

Company Facts

IPO DateMar 23, 2017
CountryCA

Frequently Asked Questions